Related Experiment Video
Updated: Dec 31, 2025

Author Spotlight: Unveiling the Role of SNF2L in Replication Fork Stability and Genome Duplication
Published on: August 23, 2024
Persistent double strand break accumulation does not precede cell death in an Olaparib-sensitive BRCA-deficient
Natalia Soledad Paviolo1, María Belén de la Vega1, María Florencia Pansa2,3
1Fundación Instituto Leloir-Instituto de Investigaciones Bioquímicas de Buenos Aires. Buenos Aires, Argentina.
Abstract:
The poly (adenosine diphosphate (ADP)-ribosyl) polymerase inhibitors (PARPi) selectively kill cancer cells with BRCA1 or BRCA2 (BRCA)-mutations. It has been proposed that cell death induction after PARPi depends on unrepaired double strand breaks (DSBs) that accumulate due to the homologous recombination deficiency of BRCA-mutated cells. Such accumulation of DSBs is inferred mainly from the high levels of DNA damage markers like phosphorylated histone H2AX. Herein, we developed a model of isogenic cell lines to show that depletion of BRCA causes PARPi-triggered cell death, replication stress (phosphorylated-H2AX and 53BP1 foci), and genomic instability. However, persistent DSBs accumulation was not detected under the same experimental conditions. Hence, at least in this cellular model, the trigger for cell death in PARPi-treated BRCA-depleted samples is not the accumulation of unrepaired DSBs. Instead, cell death better correlates with a rapid and aberrant resolution of DSBs by error-prone pathways that leads to severe chromosomic aberrations. Therefore, our results suggest that in PARPi-treated BRCA-deficient cells, chromosome aberrations may dually trigger both genomic instability and cell death.
Insights
Poly (ADP)-ribosyl) polymerase inhibitors (PARPi) kill BRCA-mutated cancer cells. In BRCA-deficient cells, PARPi-induced cell death is not caused by unrepaired double-strand breaks, but by aberrant DSB resolution leading to chromosome aberrations.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Poly (ADP)-ribosyl) polymerase inhibitors (PARPi) are effective against cancers with BRCA1/BRCA2 mutations.
- PARPi efficacy is thought to stem from unrepaired DNA double-strand breaks (DSBs) in homologous recombination-deficient cells.
Purpose of the Study:
- To investigate the precise mechanism of cell death induction by PARPi in BRCA-deficient cells.
- To determine if persistent DSB accumulation is the primary driver of PARPi-mediated cell death.
Main Methods:
- Development of an isogenic cell line model for BRCA depletion.
- Assessment of PARPi treatment effects on cell death, replication stress markers (phosphorylated-H2AX, 53BP1 foci), and genomic instability.
- Analysis of DSB accumulation and resolution pathways.
Main Results:
- BRCA depletion induced PARPi-triggered cell death, replication stress, and genomic instability.
- Persistent DSB accumulation was not observed in PARPi-treated BRCA-depleted cells.
- Cell death correlated with rapid, aberrant DSB resolution via error-prone pathways, causing chromosomal aberrations.
Conclusions:
- In this model, PARPi-induced cell death in BRCA-deficient cells is not driven by unrepaired DSBs.
- Aberrant DSB resolution and subsequent chromosome aberrations appear to be key triggers for genomic instability and cell death.
More Related Videos
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
08:31Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy
Published on: June 8, 2018
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Fixing Double-strand Breaks
Fixing Double-strand Breaks
Homologous Recombination